Recently, the "Government-Enterprise Joint Initiative for Rural Healthcare – Dalang Town Medical Donation Ceremony," guided by the Guangzhou Development District's Business Environment Reform Bureau, was held at the headquarters of innovative biopharmaceutical company Apichope Pharmaceutical Group Co., Ltd. (300723) on Guangzhou International Bio Island. During the event, Apichope successfully coordinated with the Huangpu District assistance team stationed in Dalang Town, Yangshan County, Qingyuan City, to donate urgently needed medical supplies, demonstrating a shared commitment between government and enterprises to support rural revitalization.
Wang Yuan, Executive Vice President of Apichope, emphasized the company's dedication to social responsibility and safeguarding public health in underserved communities. She affirmed Apichope's ongoing focus on Dalang Town's development and pledged further practical measures to improve local livelihoods. Liu Yinghong, Deputy Director of the Guangzhou Development District's Business Environment Reform Bureau, highlighted the donation as a tangible example of public-private collaboration in grassroots service delivery. She noted plans to expand such platforms to encourage more corporate participation in rural development initiatives.
Sun Weigang, a member of the Huangpu District assistance team in Dalang Town, detailed the region's specific healthcare needs and expressed gratitude for the joint support from government and corporate partners. At the ceremony, Liao Xianmin, Deputy Mayor of Dalang Town, presented Apichope with an honorary banner recognizing its philanthropic contributions to community health. Liao stressed that the donated supplies precisely addressed local needs, exemplifying effective public-private cooperation. He pledged rigorous management of the resources to ensure maximum public benefit.
As a pioneering local pharmaceutical firm, Apichope has consistently championed social responsibility since its founding. This donation initiative strengthens collaboration between government, businesses, aid organizations, and recipient communities. The company plans to deepen such multi-stakeholder partnerships to advance China's healthcare development.
Disclaimer: This content is an advertisement. The advertiser is responsible for the accuracy of the provided materials. The publication aims to share information and does not constitute an endorsement of the views expressed. Readers should verify content independently.
Comments